Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Goetghebeur, Pascal J.D.a; * | Wesnes, Keith A.b; c; d; e | Targum, Steven D.f
Affiliations: [a] Bracket LLC, Reading, UK | [b] Wesnes Cognition Ltd, Streatley on Thames, UK | [c] Medical School, University of Exeter, Exeter, UK | [d] Department of Psychology, Northumbria University, Newcastle, UK | [e] Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia | [f] Bracket LLC, Boston, MA, USA
Correspondence: [*] Correspondence to: Pascal Goetghebeur, Bracket LLC. The Blade, 11th floor, Abbey Square, Reading RG1 3BE, United Kingdom. Tel.: +44 (0)118955 1740; E-mail: pascal.goetghebeur@bracketglobal.com.
Abstract: Recent fMRI studies in human identified that pattern separation ability is associated with increased activity in the hippocampal dentate gyrus (DG), whereas no such DG changes are seen during pattern completion. Disruption to neurogenesis in the DG has been associated with Alzheimer’s disease (AD). In a post-hoc analysis of two large unsuccessful AD clinical trials, we examined the effect of D-cycloserine (DCS) on a specific object pattern separation measure, a component of the picture recognition task from the Cognitive Drug Research (CDR) system. This task yields a measure of pattern separation and a measure of pattern completion. Study data were available for 756 AD patients with dementia, randomized to several doses of DCS. Data were available at week 2, 6, 14, and 26 for 732, 707, 653, and 559 patients, respectively. None of the DCS doses had a statistically significant benefit over placebo on pattern completion. However, the DCS 15 mg BID dose significantly increased accuracy over placebo on the pattern separation measure by 5.1%. Further, the magnitude of the benefit of DCS 15 mg BID over placebo was almost doubled relative to the whole study population in a subset of patients whose pattern separation scores were≥2 standard deviations poorer than the CDR norm of age-matched healthy individuals at baseline. These post-hoc analyses suggest a potential value of the pattern separation task for evaluating compounds promoting neurogenesis. Further, the use of a restrictive pattern separation eligibility criterion might facilitate signal detection.
Keywords: Alzheimer’s disease, dementia, D-cycloserine, neurogenesis, pattern separation
DOI: 10.3233/JAD-181094
Journal: Journal of Alzheimer's Disease, vol. 69, no. 2, pp. 377-383, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl